27 Einträge gefunden

1. A copy number repeat polymorphism in the transactivation domain of the CEPBA gene is possibly associated with a protective effect against acquired CEBPA mutations: an analysis in 1135 patients with AML and 187 healthy controls.

   1. Schnittger, Susanne
   2. Bacher, Ulrike
   3. Eder, Christiane
   4. Lohse, Peter
   5. Haferlach, Claudia
   6. Kern, Wolfgang
   7. Haferlach, Torsten

   2011 - Forschungsinformationssystem des UKE
2. The role of multiparameter flow cytometry for disease monitoring in AML.

   1. Kern, Wolfgang
   2. Bacher, Ulrike
   3. Haferlach, Claudia
   4. Schnittger, Susanne
   5. Haferlach, Torsten

   2010 - Forschungsinformationssystem des UKE
3. Biological and clinical characterization of recurrent 14q deletions in CLL and other mature B-cell neoplasms.

   1. Reindl, Lena
   2. Bacher, Ulrike
   3. Dicker, Frank
   4. Alpermann, Tamara
   5. Kern, Wolfgang
   6. Schnittger, Susanne
   7. Haferlach, Torsten

   2010 - Forschungsinformationssystem des UKE
4. Associations between imatinib resistance conferring mutations and Philadelphia positive clonal cytogenetic evolution in CML.

   1. Schnittger, Susanne
   2. Bacher, Ulrike
   3. Dicker, Frank
   4. Kern, Wolfgang
   5. Alpermann, Tamara
   6. Haferlach, Torsten
   7. Haferlach, Claudia

   2010 - Forschungsinformationssystem des UKE
5. Comparison of cytogenetic clonal evolution patterns following allogeneic hematopoietic transplantation versus conventional treatment in patients at relapse of AML.

   1. Bacher, Ulrike
   2. Haferlach, Torsten
   3. Alpermann, Tamara
   4. Zenger, Melanie
   5. Kröger, Nicolaus
   6. Beelen, Dietrich W
   7. Kern, Wolfgang

   2010 - Forschungsinformationssystem des UKE
6. Mutations of the TET2 and CBL genes: novel molecular markers in myeloid malignancies.

   1. Bacher, Ulrike
   2. Haferlach, Claudia
   3. Schnittger, Susanne
   4. Kohlmann, Alexander
   5. Kern, Wolfgang
   6. Haferlach, Torsten

   2010 - Forschungsinformationssystem des UKE
7. Correlation of cytomorphology, immunophenotyping, and interphase fluorescence in situ hybridization in 381 patients with monoclonal gammopathy of undetermined significance and 301 patients with plasma cell myeloma.

   1. Bacher, Ulrike
   2. Haferlach, Torsten
   3. Kern, Wolfgang
   4. Alpermann, Tamara
   5. Schnittger, Susanne
   6. Haferlach, Claudia

   2010 - Forschungsinformationssystem des UKE
8. Multilineage dysplasia (MLD) in acute myeloid leukemia (AML) correlates with MDS-related cytogenetic abnormalities and a prior history of MDS or MDS/MPN but has no independent prognostic relevance: a comparison of 408 cases classified as "AML not otherwise specified" (AML-NOS) or "AML with myelodysplasia-related changes" (AML-MRC).

   1. Miesner, Miriam
   2. Haferlach, Claudia
   3. Bacher, Ulrike
   4. Weiss, Tamara
   5. Macijewski, Katja
   6. Kohlmann, Alexander
   7. Klein, Hans-Ulrich

   2010 - Forschungsinformationssystem des UKE
9. Diagnostic tools in the indications for allogeneic stem cell transplantation in myelodysplastic syndromes.

   1. Bacher, Ulrike
   2. Haferlach, Claudia
   3. Kröger, Nicolaus
   4. Schnittger, Susanne
   5. Kern, Wolfgang
   6. Wiedemann, Bettina
   7. Zander, Axel R.

   2010 - Forschungsinformationssystem des UKE
10. Detection of a t(4;14)(p16;q32) in two cases of lymphoma showing both the immunophenotype of chronic lymphocytic leukemia.

    1. Bacher, Ulrike
    2. Haferlach, Torsten
    3. Schnittger, Susanne
    4. Weiss, Tamara
    5. Burkhard, Oswald
    6. Bechtel, Britta
    7. Kern, Wolfgang

    2010 - Forschungsinformationssystem des UKE
11. Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category.

    1. Bacher, Ulrike
    2. Schnittger, Susanne
    3. Kern, Wolfgang
    4. Weiss, Tamara
    5. Haferlach, Torsten
    6. Haferlach, Claudia

    2009 - Forschungsinformationssystem des UKE
12. RQ-PCR based WT1 expression in comparison to BCR-ABL quantification can predict Philadelphia negative clonal evolution in patients with imatinib-treated chronic myeloid leukaemia.

    1. Schnittger, Susanne
    2. Bacher, Ulrike
    3. Kern, Wolfgang
    4. Tschulik, Claudia
    5. Weiss, Tamara
    6. Haferlach, Claudia
    7. Haferlach, Torsten

    2009 - Forschungsinformationssystem des UKE
13. Gene expression profiling in acute myeloid leukaemia (AML).

    1. Bacher, Ulrike
    2. Kohlmann, Alexander
    3. Haferlach, Claudia
    4. Haferlach, Torsten

    2009 - Forschungsinformationssystem des UKE
14. Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera.

    1. Schnittger, Susanne
    2. Bacher, Ulrike
    3. Haferlach, Claudia
    4. Geer, Thomas
    5. Müller, Peter
    6. Mittermüller, Johann
    7. Petrides, Petro

    2009 - Forschungsinformationssystem des UKE - frei zugänglich
15. The impact of cytomorphology, cytogenetics, molecular genetics, and immunophenotyping in a comprehensive diagnostic workup of myelodysplastic syndromes.

    1. Bacher, Ulrike
    2. Haferlach, Torsten
    3. Kern, Wolfgang
    4. Weiss, Tamara
    5. Schnittger, Susanne
    6. Haferlach, Claudia

    2009 - Forschungsinformationssystem des UKE
16. Molecular diagnostics in acute leukemias.

    1. Bacher, Ulrike
    2. Schnittger, Susanne
    3. Haferlach, Claudia
    4. Haferlach, Torsten

    2009 - Forschungsinformationssystem des UKE
17. Discussion of the applicability of microarrays: profiling of leukemias.

    1. Haferlach, Torsten
    2. Bacher, Ulrike
    3. Kohlmann, Alexander
    4. Haferlach, Claudia

    2009 - Forschungsinformationssystem des UKE
18. Characterization of 35 new cases with four different MPLW515 mutations and essential thrombocytosis or primary myelofibrosis.

    1. Schnittger, Susanne
    2. Bacher, Ulrike
    3. Haferlach, Claudia
    4. Beelen, Dietrich
    5. Bojko, Peter
    6. Bürkle, Dieter
    7. Dengler, Robert

    2009 - Forschungsinformationssystem des UKE - frei zugänglich
19. Molecular determinants of prognosis in acute myeloid leukemia (AML) with normal karyotype.

    1. Bacher, Ulrike
    2. Haferlach, Claudia

    2009 - Forschungsinformationssystem des UKE
20. The diagnosis of BCR/ABL-negative chronic myeloproliferative diseases (CMPD): a comprehensive approach based on morphology, cytogenetics, and molecular markers.

    1. Haferlach, Torsten
    2. Bacher, Ulrike
    3. Kern, Wolfgang
    4. Schnittger, Susanne
    5. Haferlach, Claudia

    2008 - Forschungsinformationssystem des UKE